Researchers identify new therapeutic approach against treatment-resistant prostate cancer

Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in the peer-reviewed journal Molecular Therapy, have led to a larger, multicenter trial that will soon be underway.

Related Keywords

Bethany Smith ,Edwin Posadas ,Neil Bhowmick ,Emily Henderson ,Oncology Research Excellence ,Lab Diagnostics Automation ,Urologic Oncology Bioinformatics Group ,Lab Diagnostics Automation Industry ,Biomedical Sciences ,Research Scientist At Cedars ,Bhowmick Lab ,Urologic Oncology Program Center ,Experimental Therapeutics Program ,Cedars Sinai Cancer ,Molecular Therapy ,Research Scientist ,Automation Industry Focus ,Urologic Oncology ,Uro Oncology Research Excellence ,Sungyong You ,Cancer ,Prostate ,Prostate Cancer ,Androgen ,Ladder ,Chemotherapy ,Clinical Trial ,Medicine ,Ncology ,Protein ,Radiation Therapy ,Research ,Surgery ,Humor ,